SCHEMBL8153559

SCHEMBL8153559

O=C(O)c1[nH]c2c(c1Br)C(O)CC2

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 1/20 0.33
PTK2 Q05397 1/20 0.32
GAA P10253 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12777398 1.00 GPR35 (0.33) GPR35PTK2GAAHSD17B10
SCHEMBL12777404 0.81 PTK2 (0.34) GPR35PTK2
SCHEMBL8151481 0.81 PTK2 (0.34) GPR35PTK2
SCHEMBL8153547 0.79 PTK2 (0.32) PTK2GAAHSD17B10
SCHEMBL8159149 0.79 PTK2 (0.45) GPR35PTK2GAAHSD17B10
SCHEMBL8153438 0.79 JAK2 (0.38) PTK2GAAHSD17B10
SCHEMBL12777384 0.79 PTK2 (0.45) GPR35PTK2GAAHSD17B10
SCHEMBL12777426 0.79 PTK2 (0.32) PTK2GAAHSD17B10
SCHEMBL12777403 0.79 JAK2 (0.38) PTK2GAAHSD17B10
SCHEMBL12777415 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20090099248-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2009-04-16 US disclosed
WO-2008089453-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099248-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE GPR35 3797/4885PTK2 1248/4885GAA 309/4885
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE GPR35 3797/4885PTK2 1248/4885GAA 309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.